Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of noncoding RNAs in metabolic reprogramming of cancer cells. | Cell Mol Biol Lett | 2023 | 37161350 | PubTator, text mining | PubMed |
| Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study. | Orphanet J Rare Dis | 2023 | 37158969 | PubTator, text mining | PubMed |
| An artificial intelligence-based approach for identifying rare disease patients using retrospective electronic health records applied for Pompe disease. | Front Neurol | 2023 | 37153672 | PubTator, text mining | PubMed |
| PLIN4-related myopathy: clinical, histological and imaging data in a large cohort of patients. | J Neurol | 2023 | 37145156 | PubTator, text mining | PubMed |
| Short-read genome sequencing allows 'en route' diagnosis of patients with atypical Friedreich ataxia. | J Neurol | 2023 | 37119371 | PubTator, text mining | PubMed |
| Novel Mutation in the Feline GAA Gene in a Cat with Glycogen Storage Disease Type II (Pompe Disease). | Animals (Basel) | 2023 | 37106898 | PubTator, text mining | PubMed |
| HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing. | Nat Commun | 2023 | 37105976 | PubTator, text mining | PubMed |
| Identifying the genetic causes of phenotypically diagnosed Pakistani mucopolysaccharidoses patients by whole genome sequencing. | Front Genet | 2023 | 37091798 | PubTator, text mining | PubMed |
| Pompe disease ascertained through The Lantern Project, 2018-2021: Next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis. | Mol Genet Metab | 2023 | 37087815 | PubTator, text mining | PubMed |
| Degeneration of muscle spindles in a murine model of Pompe disease. | Sci Rep | 2023 | 37085544 | PubTator, text mining | PubMed |
| CMPK2 restricts Zika virus replication by inhibiting viral translation. | PLoS Pathog | 2023 | 37075076 | PubTator, text mining | PubMed |
| Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. | Molecules | 2023 | 37049739 | PubTator, text mining | PubMed |
| Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial. | JAMA Neurol | 2023 | 37036722 | PubTator, text mining | PubMed |
| LMNA-related muscular dystrophy: Identification of variants in alternative genes and personalized clinical translation. | Front Genet | 2023 | 37035729 | PubTator, text mining | PubMed |
| Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase. | Front Immunol | 2023 | 37033976 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Sequencing through hyperexpanded Friedreich's ataxia-GAA repeats by nanopore technology: implications in genotype-phenotype correlation. | Brain Commun | 2023 | 37006329 | PubTator, text mining | PubMed |
| Behavioral variant frontotemporal dementia in a 23-year-old man. | Neurocase | 2023 | 36998234 | PubTator, text mining | PubMed |
| Viral Vectors in Gene Therapy: Where Do We Stand in 2023? | Viruses | 2023 | 36992407 | PubTator, text mining | PubMed |
| Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes. | Nat Commun | 2023 | 36991000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=18